EFFECT OF AN IRON-CHELATING AGENT ON LYMPHOCYTE-PROLIFERATION

被引:30
作者
BOWERN, N
RAMSHAW, IA
BADENOCHJONES, P
DOHERTY, PC
机构
来源
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE | 1984年 / 62卷 / DEC期
关键词
D O I
10.1038/icb.1984.70
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:743 / 754
页数:12
相关论文
共 18 条
[1]  
BALIGA SB, 1981, FED PROC, V40, P918
[2]  
BOWERN N, 1984, UNPUB J EXP MED
[3]   EFFECT OF IRON-CHELATING AGENTS ON INHIBITORS OF RIBONUCLEOTIDE REDUCTASE [J].
CORY, JG ;
LASATER, L ;
SATO, A .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (09) :979-984
[4]  
De Sousa M, 1978, Symp Soc Exp Biol, V32, P393
[5]  
DIMITRIU A, 1978, J IMMUNOL, V120, P1818
[6]  
EHRENBERG A, 1972, J BIOL CHEM, V247, P3485
[7]   EFFECT OF IRON-DEFICIENCY AND DESFERRIOXAMINE ON DNA-SYNTHESIS IN HUMAN CELLS [J].
HOFFBRAND, AV ;
GANESHAGURU, K ;
HOOTON, JWL ;
TATTERSALL, MHN .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :517-526
[8]  
JOYNSON DHM, 1972, LANCET, V2, P1058
[9]  
KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758
[10]   LONG-TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA [J].
MODELL, CB ;
BECK, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 232 (MAY24) :201-210